 |
 |
 |
FDA
Home Page | Search FDA Site |
FDA A-Z Index | Contact FDA
Under sections 735 and 736 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379g and 379h), FDA has the authority to assess and collect user fees for certain drug and biologics license applications and supplements. Under this authority, pharmaceutical companies pay fees for certain new human drug applications, biologics applications, and supplements submitted to the agency for review. Because the submission of user fees concurrently with applications and supplements is required, review of an application by FDA cannot begin until the fee has been submitted. Form FDA 3397, the PDUFA user fee cover sheet, is designed to provide the minimum necessary information to determine whether a fee is required for review of an application, to determine the amount of the fee required, and to help FDA track payments.
The form provides a cross-reference of the fee submitted for an application with the actual application by using a unique number tracking system to assign the user fee payment identification number. The information collected is used by FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) to initiate the administrative screening of new drug applications, biologics license applications, and supplemental applications.
FDA offers you the ability to complete a PDUFA User Fee Cover Sheet online and submit it electronically. To fill out the form online, you need Microsoft Internet Explorer 5.5 or higher or Netscape Navigator 4.7 or higher.
Read the instructions below and then go to the PDUFA User Fee Coversheet to fill out the form.
1. You will register online by providing the following information:
2. Fill out the PDUFA User Fee Cover Sheet. Please answer a series of questions regarding the type of application being submitted for FDA's review. You will have the opportunity to view the cover sheet in draft form before submitting it to FDA. You have not submitted your cover sheet until you receive a user fee payment identification number.
3. When you are done, click the SUBMIT button to complete the cover sheet submission process. A form will appear with an electronically generated user fee payment identification number that is located in the upper right-hand corner, beginning with the letters PD. This number will assist FDA in tracking your payment and submission for the review process. Please print a copy for your files to send with your payment and for your submission to CDER and CBER.
Please send a printed copy of the completed PDUFA User Fee Cover Sheet along with a check, bank draft, or U.S. Postal money order made payable to the Food and Drug Administration for the fee amount due. Remember to include the user fee payment identification number, beginning with "PD," the BLA/NDA number, and the FDA P.O. Box on the enclosed check.
Food and Drug Administration
P.O. Box 70963
Charlotte, NC 28272-0963
Note: In no case should payment be submitted with the application.
Wachovia Bank
Attn: Food and Drug Administration, Lockbox 70963
1525 West WT Harris Blvd, Room NC0810
Charlotte, NC 28262
Note: This address is for courier delivery only.
Wire Transfer Payment
US Department of Treasury
TREAS NYC
33 Liberty Street
New York, NY 10045
FDA Deposit Account Number: 75060099
US Department of Treasury routing/transit number: 021030004
SWIFT Number: FRNYUS33
Please include the user fee payment identification number, beginning with "PD", the BLA/NDA number and ensure that the fee that your bank will charge for the wire transfer is added to your fee payment.
Contact: Beverly Friedman or Mike Jones at 301-796-3602
FDA Center for Drug Evaluation and Research
Contact: Carla Vincent at 301-827-3503
FDA Center for Biologics Evaluation and Research
Contact: FDA User Fee Financial Support Team at (301) 827-9539 or userfees@fda.gov.
OMB No. 0910-0297
Form FDA 3397 (01/07)